Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High-bone-mass disease and LRP5.

Literature DB >> 15141052

High-bone-mass disease and LRP5.

Michael P Whyte, William H Reinus, Steven Mumm.

Abstract

Entities: Disease Gene Mutation

Mesh：

Substances：

Year: 2004 PMID： 15141052 DOI： 10.1056/NEJM200405133502017

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

19 in total

Review 1. Diseases of Wnt signaling.

Authors: Mark L Johnson; Nalini Rajamannan
Journal: Rev Endocr Metab Disord Date: 2006-06 Impact factor: 6.514

2. Rapid skeletal turnover in a radiographic mimic of osteopetrosis.

Authors: Michael P Whyte; Katherine L Madson; Steven Mumm; William H McAlister; Deborah V Novack; Jo C Blair; Timothy R Helliwell; Marina Stolina; Laurence J Abernethy; Nicholas J Shaw
Journal: J Bone Miner Res Date: 2014-12 Impact factor: 6.741

3. Impact of gain-of-function mutations in the low-density lipoprotein receptor-related protein 5 (LRP5) on glucose and lipid homeostasis.

Authors: D Foer; M Zhu; R L Cardone; C Simpson; R Sullivan; S Nemiroff; G Lee; R G Kibbey; K F Petersen; K L Insogna
Journal: Osteoporos Int Date: 2017-03-10 Impact factor: 4.507

4. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling.

Authors: Minrong Ai; Sheri L Holmen; Wim Van Hul; Bart O Williams; Matthew L Warman
Journal: Mol Cell Biol Date: 2005-06 Impact factor: 4.272

5. Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5.

Authors: C A Simpson; D Foer; G S Lee; J Bihuniak; B Sun; R Sullivan; J Belsky; K L Insogna
Journal: Osteoporos Int Date: 2014-06-14 Impact factor: 4.507

High-bone-mass disease and LRP5.

Review 1. Diseases of Wnt signaling.

2. Rapid skeletal turnover in a radiographic mimic of osteopetrosis.

3. Impact of gain-of-function mutations in the low-density lipoprotein receptor-related protein 5 (LRP5) on glucose and lipid homeostasis.

4. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling.

5. Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5.

6. Serum serotonin levels and bone in rheumatoid arthritis patients.

7. Measurement of plasma, serum, and platelet serotonin in individuals with high bone mass and mutations in LRP5.

Review 8. Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management.

9. A specific role for phosphoinositide 3-kinase and AKT in osteoblasts?

10. High bone mass is associated with an increased prevalence of joint replacement: a case-control study.